Fluorescence PCR

Multiplex chaiyo-nguva PCR |Melting curve tekinoroji |Akarurama |UNG System |Liquid & lyophilized reagent

Fluorescence PCR

  • Poliovirus Type Ⅰ

    Poliovirus Type Ⅰ

    Iyi kit inokodzera kuongororwa kwemhando yepoliovirus rudzi I nucleic acid mumasampuli ezvituru zvevanhu mu vitro.

  • Mhando yePoliovirus Ⅱ

    Mhando yePoliovirus Ⅱ

    Iyi kit inokodzera kuongororwa kwemhando yePoliovirus Type Ⅱnucleic acid mumasampuli ezvituru zvevanhu mu vitro.

  • Enterovirus 71 (EV71)

    Enterovirus 71 (EV71)

    Iyi kit inoitirwa in vitro qualitative yekuona kwe enterovirus 71 (EV71) nucleic acid mune oropharyngeal swabs uye herpes fluid samples yevarwere vane ruoko-tsoka-muromo chirwere.

  • Enterovirus Universal

    Enterovirus Universal

    Ichi chigadzirwa chakagadzirirwa in vitro qualitative kuonekwa kwe enteroviruses mune oropharyngeal swabs uye herpes fluid samples.Kiti iyi ndeyekubatsira kuongorora chirwere cheruoko-rutsoka-muromo.

  • Herpes Simplex Virus Type 1

    Herpes Simplex Virus Type 1

    Iyi kit inoshandiswa pakuongorora kwemhando yeHerpes Simplex Virus Type 1 (HSV1).

  • Chlamydia Trachomatis, Neisseria Gonorrhoeae uye Trichomonas vaginalis

    Chlamydia Trachomatis, Neisseria Gonorrhoeae uye Trichomonas vaginalis

    Iyo kit inoitirwa in vitro qualitative yekuongorora yeChlamydia trachomatis (CT), Neisseria gonorrhoeae (NG)uyeTrichomonal vaginitis (TV) mumurume urethral swab, cervical swab yechikadzi, uye sampuli dzechikadzi dzechikadzi, uye inopa rubatsiro mukuongororwa uye kurapwa kwevarwere vane genitourinary tract infection.

  • Trichomonas Vaginalis Nucleic Acid

    Trichomonas Vaginalis Nucleic Acid

    Iyi kit inoshandiswa pakuonekwa kwehunhu hweTrichomonas vaginalis nucleic acid mumunhu urogenital turakiti secretion samples.

  • Zvirwere zvekufema zvakasanganiswa

    Zvirwere zvekufema zvakasanganiswa

    Iyi kit inoshandiswa pakuongorora kwemhando yekufema hutachiona mu nucleic acid yakatorwa kubva kuvanhu oropharyngeal swab samples.

    Iyi modhi inoshandiswa pakuonekwa kwemhando ye2019-nCoV, hutachiona hwefuruwenza A, hutachiona hwefuruwenza B uye kufema syncytial virus nucleic acids mumunhu oropharyngeal swab samples.

  • Zvirwere zvekufema zvakasanganiswa

    Zvirwere zvekufema zvakasanganiswa

    Iyi kit inoshandiswa pakuongorora in vitro qualitative yekuona hutachiona hwefuruwenza A, furuwenza B, kufema syncytial virus, adenovirus, human rhinovirus uye mycoplasma pneumoniae nucleic acids mumunhu nasopharyngeal swabs uye oropharyngeal swab samples.Mhedzisiro yebvunzo inogona kushandiswa kubatsira kuongororwa kwehutachiona hwehutachiona hwekufema, uye inopa ebetsero molecular diagnostic hwaro hwekuongororwa uye kurapwa kwekufema hutachiona hwepathogen.

  • 14 Mhando dzeGenitorinary Tract Infection Pathogen

    14 Mhando dzeGenitorinary Tract Infection Pathogen

    Iyo kit yakagadzirirwa in vitro qualitative kuonekwa kweChlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma hominis (Mh), Herpes simplex virus type 1 (HSV1), Ureaplasma urealyticum (UU), Herpes simplex virus type 2 ( HSV2), Ureaplasma parvum (UP), Mycoplasma genitalium (Mg), Candida albicans (CA), Gardnerella vaginalis (GV), Trichomonal vaginitis (TV), Boka B streptococci (GBS), Haemophilus ducreyi (HD), uye Treponema pallidum ( TP) mumurume urethral swab, cervical swab yechikadzi, uye sampuli dzechikadzi dzechikadzi, uye inopa rubatsiro mukuongororwa uye kurapwa kwevarwere vane genitourinary tract infection.

  • SARS-CoV-2/furuwenza A /furuwenza B

    SARS-CoV-2/furuwenza A /furuwenza B

    Iyi kit inokodzera in vitro qualitative yekuona SARS-CoV-2, furuwenza A uye furuwenza B nucleic acid ye nasopharyngeal swab uye oropharyngeal swab samples ndedzipi dzevanhu vaifungidzirwa hutachiona hweSARS-CoV-2, furuwenza A uye furuwenza. B. Inogonawo kushandiswa mukufungidzira mabayo uye kunofungidzirwa kuti makustakesi uye kuona uye kuzivikanwa kweSARS-CoV-2, furuwenza A uye furuwenza B nucleic acid mu nasopharyngeal swab uye oropharyngeal swab samples dze novel Coronavirus chirwere mune mamwe mamiriro.

  • 14 Mhando dzeHuman Papillomavirus ine njodzi huru (16/18/52 Typing)

    14 Mhando dzeHuman Papillomavirus ine njodzi huru (16/18/52 Typing)

    Iyo kit inoshandiswa pakuongorora in vitro qualitative yemhando gumi nemana epapillomaviruses evanhu (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) zvimedu zve nucleic acid. mumunhuweti samples, cervical swab samples dzemukadzi, uye dzechikadzi swab dzemukadzi, pamwe neHPV 16/18./52kutaipa, kubatsira mukuongororwa uye kurapwa kwehutachiona hweHPV.